137421-60-4

Basic information

• Product Name: 3H-Imidazo[4,5-b]pyridine, 2-ethyl-5,7-dimethyl-3-[(4-nitrophenyl)methyl]-
• CAS NO: 137421-60-4
• Molecular Formula: C17H18N4O2
• Molecular Weight: 310.356
• Mol File: 137421-60-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3H-Imidazo[4,5-b]pyridine, 2-ethyl-5,7-dimethyl-3-[(4-nitrophenyl)methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 3H-Imidazo[4,5-b]pyridine, 2-ethyl-5,7-dimethyl-3-[(4-nitrophenyl)methyl]-(137421-60-4)
• EPA Substance Registry System: 3H-Imidazo[4,5-b]pyridine, 2-ethyl-5,7-dimethyl-3-[(4-nitrophenyl)methyl]-(137421-60-4)

Safety Data

• Hazardous Substances Data: 137421-60-4(Hazardous Substances Data)

Upstream product

• 133240-06-9 5,7-dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine 
• 100-11-8 1-bromomethyl-4-nitro-benzene 
• 133240-06-9 2-ethyl-5,7-dimethyl-1H-imidazo[4,5-b]pyridine 
• 68175-10-0 2-butyl-1H-imidazo[4,5-b]pyridine 

Downstream Products

• 137421-61-5 4-[(5,7-Dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine-3-yl)methyl]benzeneamine 
• 151954-63-1 3-<<4-methyl>-N-ethylamino>phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-48-2 3-<<4-methyl>amino>phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-37-9 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-64-2 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-62-0 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-59-5 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-60-8 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-49-3 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 137421-74-0 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-53-9 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 151954-61-9 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 137421-73-9 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 
• 137421-71-7 3-<<4-phenyl>methyl>-5,7-dimethyl-2-ethyl-3H-imidazo<4,5-b>pyridine 

Relevant articles and documents

PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUTROPHILIC INFLAMMATION DISEASE

The present invention provides a preventive and/or therapeutic agent for neutrophilic inflammatory diseases which comprises, as an active ingredient, a bicyclic heterocyclic compound represented by formula (I): [wherein R 1 represents a hydrogen atom, substituted or unsubstituted alkyl, or the like, A 1 -A 2 -A 3 -A 4 represents N=CR 3 -CR 4 =CR 5 (wherein R 3 , R 4 , and R 5 are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, and the like), Q represents substituted or unsubstituted phenylene, and the like, and T represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aroyl, and the like].

Process for producing quinolin-2-yl benzoic acid compounds

A quinolin-2-yl benzoic acid compound useful as intermediates of angiotensin II antagonists which are effective for treating hypertension can be produced by decarboxylating a 2-carboxyphenyl-4-quinolinecarboxylic acid compound in which two carboxyl groups are not substituted and a benzene ring and a quinoline ring may have substituents inert to said decarboxylation reaction.

ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED PYRIDOIMIDAZOLYL RING

Substituted heterocycles attached through a methylene bridge to novel substituted phenyl derivatives of the Formula I are useful as angiotensin II antagonists. STR1